Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00382824 · ClinicalTrials.gov registry record · NA
Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP)
A NA study, sponsored by Lahey Clinic.
- Completed
- Registry status
- NA
- Development phase
- 61
- Enrollment target
NCT00382824 is a NA study that has completed, run by Lahey Clinic. The registered enrollment target is 61 participants.
The verdict
NCT00382824, a NA study, has completed, sponsored by Lahey Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 61 participants
- Enrollment target
Study Summary
The clinical syndrome of PSP responds poorly to all available forms of therapy used in Parkinson's Disease (PD). Currently, no effective treatment exists. Coenzyme Q10 in high doses has been shown to be a beneficial therapy in PD and might possibly be a beneficial therapy for PSP. This study will compare the efficacy, safety and tolerability of Coenzyme Q10 versus placebo in patients with atypical parkinsonian syndrome, progressive supranuclear palsy (PSP).
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Coenzyme Q10
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2006-09 |
| Est. Completion | 2015-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00382824
The ClinicalTrials.gov registry entry for NCT00382824 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lahey Clinic, which has 43 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00382824 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00382824 about?
NCT00382824 is a clinical study titled "Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP)". The clinical syndrome of PSP responds poorly to all available forms of therapy used in Parkinson's Disease (PD). Currently, no effective treatment exists. Coenzyme Q10 in high doses has been shown to be a beneficial therapy in PD and might possibly be a beneficial therapy for PSP. This study will co...
What is the current status of trial NCT00382824?
This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2006-09. Estimated completion is 2015-01.
What interventions are being tested in trial NCT00382824?
The interventions under investigation include: Placebo (OTHER), Coenzyme Q10 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00382824?
This trial is sponsored by Lahey Clinic, which has 43 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.